Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children

RT @GrupoPKgen_SEFH: Population #Pharmacokinetic Model to Optimize #Cefotaxime Dosing Regimen in Critically Ill Children https://t.co/OnTg7…

Population #Pharmacokinetic Model to Optimize #Cefotaxime Dosing Regimen in Critically Ill Children https://t.co/OnTg7VnZcC

RT @jordovas: Cefotaxime i.v. continuous infusion in critical ill children: rationale pk modelling and feasibility. https://t.co/RREMdP7wx7

RT @jordovas: Cefotaxime i.v. continuous infusion in critical ill children: rationale pk modelling and feasibility. https://t.co/RREMdP7wx7

RT @jordovas: Cefotaxime i.v. continuous infusion in critical ill children: rationale pk modelling and feasibility. https://t.co/RREMdP7wx7

Cefotaxime i.v. continuous infusion in critical ill children: rationale pk modelling and feasibility. https://t.co/RREMdP7wx7

RT @GrupoPKgen_SEFH: #Cefotaxime 100 mg·kg−1·day−1 by continuous infusion --> 100% probability of target attainment in ICU children https:/…

RT @GrupoPKgen_SEFH: #Cefotaxime 100 mg·kg−1·day−1 by continuous infusion --> 100% probability of target attainment in ICU children https:/…

#Cefotaxime 100 mg·kg−1·day−1 by continuous infusion --> 100% probability of target attainment in ICU children https://t.co/dAOxCXw6Mm